EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Correlation between pathologic complete response, event-free survival/disease-free survival and overall survival in neoadjuvant and/or adjuvant HR+/HER2-breast cancer

Anagha Gogate, Sandip Ranjan, Amit Kumar, Hitesh Bhandari, Eros Papademetriou, Inkyu Kim, Ravi Potluri

Frontiers in Oncology · 02.05.2023 · 13

DOI: 10.3389/fonc.2023.1119102 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Oncology, online erschienen am 02.05.2023. Verfasst von Anagha Gogate und 6 weiteren Autor:innen. Beteiligte Einrichtung: WWHEOR, Bristol Myers Squibb, Princeton, NJ, United States. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The study’s purpose was to evaluate the correlation between overall survival (OS) and its potential surrogate endpoints: pathologic complete response (pCR) and event-free survival (EFS)/disease-free survival (DFS) in neoadjuvant and/or adjuvant HR+/HER2- breast cancer.

Methods

Systematic search was performed in MEDLINE, EMBASE, Cochrane Library databases and other relevant sources to identify literature that have reported outcomes of interest in the target setting. The strength of correlation of EFS/DFS with OS, pCR with OS, and pCR with EFS/DFS was measured using Pearson’s correlation coefficient (r) based on weighted regression analysis. For Surrogate Endpoint-True Endpoint pairs where correlation was found to be moderate, surrogate threshold effect (STE) was estimated using a mixed-effects model. Sensitivity analyses were conducted on the scale and weights used and removing outlier data.

Results

Moderate correlation was observed of relative measures [log(HR)] of EFS/DFS and OS (r = 0.91; 95% CI: 0.83, 0.96, p < 0.0001). STE for HR EFS/DFS was estimated to be 0.73. Association between EFS/DFS at 1, 2 and 3 years with OS at 4- and 5-year landmarks was moderate. Relative treatment effects of pCR and EFS/DFS were not strongly associated (r: 0.24; 95% CI: -0.63, 0.84, p = 0.6028). Correlation between pCR and OS was either not evaluated due to inadequate sample size (relative outcomes) or weak (absolute outcomes). Results obtained in the sensitivity analyses were similar to base scenario.

Conclusion

EFS/DFS were moderately correlated with OS in this trial-level analysis. They may be considered as valid surrogates for OS in HR+/HER2- breast cancer.

Schlagwörter

Stichwörter der Autor:innen

HR+/HER2- breast cancerneoadjuvant/adjuvantoverall survivalsurrogate endpointssurrogate threshold effect

Autor:innen und Institutionen

  • WWHEOR, Bristol Myers Squibb, Princeton, NJ, United States.
  • HEOR, SmartAnalyst India Pvt. Ltd., Gurgaon, India.
  • HEOR, SmartAnalyst Inc., New York, NY, United States.

Zitieren

APA

Gogate, A., Ranjan, S., Kumar, A., Bhandari, H., Papademetriou, E., Kim, I., & Potluri, R. (2023). Correlation between pathologic complete response, event-free survival/disease-free survival and overall survival in neoadjuvant and/or adjuvant HR+/HER2-breast cancer. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1119102

Vancouver

Gogate A, Ranjan S, Kumar A, Bhandari H, Papademetriou E, Kim I, et al. Correlation between pathologic complete response, event-free survival/disease-free survival and overall survival in neoadjuvant and/or adjuvant HR+/HER2-breast cancer. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1119102

BibTeX
@article{Gogate2023,
  author = {Gogate, Anagha and Ranjan, Sandip and Kumar, Amit and Bhandari, Hitesh and Papademetriou, Eros and Kim, Inkyu and Potluri, Ravi},
  title = {Correlation between pathologic complete response, event-free survival/disease-free survival and overall survival in neoadjuvant and/or adjuvant HR+/HER2-breast cancer},
  journal = {Frontiers in Oncology},
  year = {2023},
  volume = {13},
  doi = {10.3389/fonc.2023.1119102}
}
Kostenlos starten →